Generation Days Payables Outstanding from 2010 to 2024

GBIO Stock  USD 1.16  0.03  2.52%   
Generation Bio Days Payables Outstanding yearly trend continues to be very stable with very little volatility. Days Payables Outstanding is likely to drop to 10.19. During the period from 2010 to 2024, Generation Bio Days Payables Outstanding quarterly data regression pattern had sample variance of  37,179 and median of  440.78. View All Fundamentals
 
Days Payables Outstanding  
First Reported
2010-12-31
Previous Quarter
10.7284345
Current Value
10.19
Quarterly Volatility
192.81964959
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Generation Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Generation Bio's main balance sheet or income statement drivers, such as Net Interest Income of 12.5 M, Interest Income of 12.5 M or Depreciation And Amortization of 3.8 M, as well as many indicators such as Price To Sales Ratio of 19.69, Dividend Yield of 0.0 or PTB Ratio of 0.55. Generation financial statements analysis is a perfect complement when working with Generation Bio Valuation or Volatility modules.
  
Check out the analysis of Generation Bio Correlation against competitors.

Latest Generation Bio's Days Payables Outstanding Growth Pattern

Below is the plot of the Days Payables Outstanding of Generation Bio Co over the last few years. It is Generation Bio's Days Payables Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Generation Bio's overall financial position and show how it may be relating to other accounts over time.
Days Payables Outstanding10 Years Trend
Slightly volatile
   Days Payables Outstanding   
       Timeline  

Generation Days Payables Outstanding Regression Statistics

Arithmetic Mean311.14
Geometric Mean179.73
Coefficient Of Variation61.97
Mean Deviation172.85
Median440.78
Standard Deviation192.82
Sample Variance37,179
Range431
R-Value(0.82)
Mean Square Error13,051
R-Squared0.67
Significance0.0002
Slope(35.40)
Total Sum of Squares520,512

Generation Days Payables Outstanding History

2024 10.19
2023 10.73
2022 47.1
2021 162.93
2020 28.4

About Generation Bio Financial Statements

Generation Bio investors utilize fundamental indicators, such as Days Payables Outstanding, to predict how Generation Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Days Payables Outstanding 10.73  10.19 

Pair Trading with Generation Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Generation Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Generation Bio will appreciate offsetting losses from the drop in the long position's value.

Moving together with Generation Stock

  0.94VALN Valneva SE ADRPairCorr
  0.93ERNA Eterna TherapeuticsPairCorr

Moving against Generation Stock

  0.84BMY Bristol Myers SquibbPairCorr
  0.79DYAI Dyadic InternationalPairCorr
  0.78ESPR Esperion TherapeuticsPairCorr
  0.65GILD Gilead SciencesPairCorr
  0.4DNA Ginkgo Bioworks Holdings Sell-off TrendPairCorr
The ability to find closely correlated positions to Generation Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Generation Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Generation Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Generation Bio Co to buy it.
The correlation of Generation Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Generation Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Generation Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Generation Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Generation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Generation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Generation Bio Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Generation Bio Co Stock:
Check out the analysis of Generation Bio Correlation against competitors.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.19)
Revenue Per Share
0.28
Quarterly Revenue Growth
2.52
Return On Assets
(0.19)
Return On Equity
(0.86)
The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.